A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Boehringer Ingelheim
Boehringer Ingelheim
Columbia University
Tvardi Therapeutics, Incorporated
NantBioScience, Inc.
Xencor, Inc.
Pfizer
Celldex Therapeutics
Xencor, Inc.
Quadriga Biosciences, Inc.
Xencor, Inc.
Pfizer
Zhujiang Hospital
Masonic Cancer Center, University of Minnesota
Santa Maria Biotherapeutics
Curis, Inc.
Memorial Sloan Kettering Cancer Center
Duke University
University of Chicago
Duke University